Therapeutic potential for existing and novel forms of natriuretic peptides.
Chen
Horng H
HH
Mayo Clinic College of Medicine, Rochester, MN 55905, USA. chen.horng@mayo.edu
Burnett
John C
JC
D001249:Asthma / Q000188:drug therapy*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007674:Kidney Diseases / Q000209:etiology / Q000517:prevention & control*; D009203:Myocardial Infarction / Q000150:complications; D045265:Natriuretic Peptides / Q000502:physiology / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D020257:Ventricular Remodeling / Q000187:drug effects
D045265:Natriuretic Peptides